Get started
VICORE PHARMA HOLDING ABVICORE PHARMA HOLDING ABVICORE PHARMA HOLDING AB

VICORE PHARMA HOLDING AB

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

VICO chart


Full chart

VICO upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.52 B‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.14 SEK
Net income (FY)
‪−168.63 M‬ SEK
Revenue (FY)
‪109.35 M‬ SEK
Shares float
‪185.04 M‬
Beta (1Y)
0.13

Employees


Employees (FY)
29
Change (1Y)
+4 +16.00%
Revenue / Employee (1Y)
‪3.77 M‬ SEK
Net income / Employee (1Y)
‪−5.81 M‬ SEK

About VICORE PHARMA HOLDING AB


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Ahmed S. Mousa
Website
vicorepharma.com
Headquarters
Stockholm
Founded
2001
ISIN
SE0007577895
FIGI
BBG00BM6H589
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

VICO news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as VICO.

Frequently Asked Questions


The current price of VICO is 6.52 SEK — it has increased by 1.23% in the past 24 hours. Watch VICORE PHARMA HOLDING AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange VICORE PHARMA HOLDING AB stocks are traded under the ticker VICO.
VICO stock has fallen by −0.30% compared to the previous week, the month change is a −11.91% fall, over the last year VICORE PHARMA HOLDING AB has showed a −61.27% decrease.
We've gathered analysts' opinions on VICORE PHARMA HOLDING AB future price: according to them, VICO price has a max estimate of 40.00 SEK and a min estimate of 15.00 SEK. Watch VICO chart and read a more detailed VICORE PHARMA HOLDING AB stock forecast: see what analysts think of VICORE PHARMA HOLDING AB and suggest that you do with its stocks.
VICO reached its all-time high on Dec 28, 2020 with the price of 37.26 SEK, and its all-time low was 4.86 SEK and was reached on Feb 25, 2016. View more price dynamics on VICO chart.
See other stocks reaching their highest and lowest prices.
VICO stock is 3.58% volatile and has beta coefficient of 0.13. Track VICORE PHARMA HOLDING AB stock price on the chart and check out the list of the most volatile stocks — is VICORE PHARMA HOLDING AB there?
Today VICORE PHARMA HOLDING AB has the market capitalization of ‪1.52 B‬, it has decreased by −9.32% over the last week.
Yes, you can track VICORE PHARMA HOLDING AB financials in yearly and quarterly reports right on TradingView.
VICORE PHARMA HOLDING AB is going to release the next earnings report on May 6, 2025. Keep track of upcoming events with our Earnings Calendar.
VICO earnings for the last quarter are −0.40 SEK per share, whereas the estimation was −0.36 SEK resulting in a −12.10% surprise. The estimated earnings for the next quarter are −0.37 SEK per share. See more details about VICORE PHARMA HOLDING AB earnings.
VICORE PHARMA HOLDING AB revenue for the last quarter amounts to ‪5.10 M‬ SEK, matching the estimated figure, and no changes in revenue are expected for the next quarter.
VICO net income for the last quarter is ‪−84.08 M‬ SEK, while the quarter before that showed ‪−59.95 M‬ SEK of net income which accounts for −40.25% change. Track more VICORE PHARMA HOLDING AB financial stats to get the full picture.
No, VICO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 29 employees. See our rating of the largest employees — is VICORE PHARMA HOLDING AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VICORE PHARMA HOLDING AB EBITDA is ‪−188.12 M‬ SEK, and current EBITDA margin is −172.04%. See more stats in VICORE PHARMA HOLDING AB financial statements.
Like other stocks, VICO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VICORE PHARMA HOLDING AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VICORE PHARMA HOLDING AB technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VICORE PHARMA HOLDING AB stock shows the sell signal. See more of VICORE PHARMA HOLDING AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.